INNA-051
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Viral vector |
| Clinical data | |
| Routes of administration | Intranasal |
| Part of a series on the |
| COVID-19 pandemic |
|---|
|
|
International response
|
|
Medical response
|
|
Economic impact and recession
|
|
Impacts
|
| COVID-19 portal |
INNA-051 is a COVID-19 vaccine candidate developed by Ena Respiratory.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.